The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2019

Filed:

Nov. 10, 2016
Applicant:

Omeros Corporation, Seattle, WA (US);

Inventors:

George A. Gaitanaris, Seattle, WA (US);

John E. Bergmann, Albany, CA (US);

Alexander Gragerov, Seattle, WA (US);

John Hohmann, Seattle, WA (US);

Fusheng Li, Seattle, WA (US);

Linda Madisen, Seattle, WA (US);

Kellie L. McIlwain, Washington, DC (US);

Maria N. Pavlova, Seattle, WA (US);

Demetri Vassilatis, Seattle, WA (US);

Hongkui Zeng, Seattle, WA (US);

Assignee:

Omeros Corporation, Seattle, WA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/027 (2006.01); C07K 14/72 (2006.01); C12Q 1/6883 (2018.01); A61K 49/00 (2006.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0278 (2013.01); A61K 49/0008 (2013.01); C07K 14/723 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5023 (2013.01); A01K 2217/00 (2013.01); A01K 2217/052 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A61K 38/00 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/726 (2013.01); G01N 2800/04 (2013.01); G01N 2800/28 (2013.01); G01N 2800/50 (2013.01);
Abstract

The present invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, as well as methods for their production. The polypeptides and polynucleotides are useful, for example, in methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g., agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention, and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR activity or levels.


Find Patent Forward Citations

Loading…